Abstract | BACKGROUND: METHODS: A randomized, double-blind, controlled trial that included women at 36-41 weeks of gestation with non-cephalic presentations was performed. Women were randomized to receive either a remifentanil infusion at 0.1 μg/kg/min and demand boluses of 0.1 μg/kg, or saline placebo. The primary outcome was the numerical rating pain score (0-10) after external cephalic version. RESULTS: CONCLUSION:
|
Authors | H Muñoz, S Guerra, P Perez-Vaquero, C Valero Martinez, F Aizpuru, A Lopez-Picado |
Journal | International journal of obstetric anesthesia
(Int J Obstet Anesth)
Vol. 23
Issue 1
Pg. 52-7
(Feb 2014)
ISSN: 1532-3374 [Electronic] Netherlands |
PMID | 24388737
(Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
|
Copyright | Copyright © 2013 Elsevier Ltd. All rights reserved. |
Chemical References |
- Analgesics, Opioid
- Piperidines
- Placebos
- Remifentanil
|
Topics |
- Adult
- Analgesia
(methods)
- Analgesics, Opioid
(adverse effects, therapeutic use)
- Bradycardia
(chemically induced)
- Breech Presentation
(therapy)
- Dizziness
(chemically induced)
- Double-Blind Method
- Female
- Fetal Diseases
(chemically induced)
- Humans
- Nausea
(chemically induced)
- Pain
(drug therapy, etiology)
- Pain Management
(methods)
- Patient Satisfaction
(statistics & numerical data)
- Piperidines
(adverse effects, therapeutic use)
- Placebos
- Pregnancy
- Remifentanil
- Treatment Outcome
- Version, Fetal
(adverse effects, methods)
- Vomiting
(chemically induced)
|